All Stories

  1. Personalized nutrition in ageing society: redox control of major-age related diseases through the NutRedOx Network (COST Action CA16112)
  2. Natural scaffolds in anticancer therapy and precision medicine
  3. The Fungal Metabolite Eurochevalierine, a Sequiterpene Alkaloid, Displays Anti-Cancer Properties through Selective Sirtuin 1/2 Inhibition
  4. Tubulin-binding anticancer polysulfides induce cell death via mitotic arrest and autophagic interference in colorectal cancer
  5. Anticancer and Immunogenic Properties of Cardiac Glycosides
  6. The Forty-Sixth Euro Congress on Drug Synthesis and Analysis: Snapshot †
  7. Discovery and Characterization of R/S-N-3-Cyanophenyl-N′-(6-tert-butoxycarbonylamino-3,4-dihydro-2,2-dimethyl-2H-1-benzopyran-4-yl)urea, a New Histone Deacetylase Class III Inhibitor Exerting Antiproliferative Activity against Cancer Cell Lines
  8. Cardiac glycosides: From molecular targets to immunogenic cell death
  9. Natural Compound Histone Deacetylase Inhibitors (HDACi): Synergy with Inflammatory Signaling Pathway Modulators and Clinical Applications in Cancer
  10. Bcl-2 protein family expression pattern determines synergistic pro-apoptotic effects of BH3 mimetics with hemisynthetic cardiac glycoside UNBS1450 in acute myeloid leukemia
  11. 4α-Methylated steroids with cytotoxic activity from the soft coral Litophyton mollis
  12. Natural Compound-Generated Oxidative Stress: From Bench to Bedside
  13. The Eighth Central European Conference “Chemistry towards Biology”: Snapshot
  14. Non-canonical programmed cell death mechanisms triggered by natural compounds
  15. Garlic-derived natural polysulfanes as hydrogen sulfide donors: Friend or foe?
  16. Discovery and characterization of Isofistularin-3, a marine brominated alkaloid, as a new DNA demethylating agent inducing cell cycle arrest and sensitization to TRAIL in cancer cells
  17. Roles of Apoptosis and Cellular Senescence in Cancer and Aging
  18. One-Pot Synthesis of Benzopyran-4-ones with Cancer Preventive and Therapeutic Potential
  19. Phenolic Contents and In vitro Pharmacological Activities of Methanolic Extract of Pterocarpus erinaceus Poir. Stem Bark (Fabaceae)
  20. Guidelines for the use and interpretation of assays for monitoring autophagy (3rd edition)
  21. 4-Hydroxybenzoic acid derivatives as HDAC6-specific inhibitors modulating microtubular structure and HSP90α chaperone activity against prostate cancer
  22. Curcumin
  23. Cytotoxic, Antiproliferative and Pro-Apoptotic Effects of 5-Hydroxyl-6,7,3′,4′,5′-Pentamethoxyflavone Isolated from Lantana ukambensis
  24. Cell type-dependent ROS and mitophagy response leads to apoptosis or necroptosis in neuroblastoma
  25. Flavonoid glycosides from Olax mannii: Structure elucidation and effect on the nuclear factor kappa B pathway
  26. Perspectives in Medicinal Chemistry: DNA Methylation and Demethylation Mechanisms as Therapeutic Targets?
  27. Role of Histone Acetylation in Cell Cycle Regulation
  28. Epigenetic alterations as a universal feature of cancer hallmarks and a promising target for personalized treatments
  29. Editorial (Thematic Issue: Novel Pharmaceutical Approaches by Natural Compound-Derived Epigenetic Regulators: Epigenetic Readers, Writers and Erasers as Therapeutic Targets)
  30. Coffee provides a natural multitarget pharmacopeia against the hallmarks of cancer
  31. Natural compounds and pharmaceuticals reprogram leukemia cell differentiation pathways
  32. Identification and re-addressing of a transcriptionally permissive locus in the porcine genome
  33. Effects of Natural Products on Mcl-1 Expression and Function
  34. ChemInform Abstract: Tanzawaic Acids Isolated from a Marine-Derived fungus of the Genus Penicillium with Cytotoxic Activities.
  35. Natural and Synthetic Flavonoids: Structure–Activity Relationship and Chemotherapeutic Potential for the Treatment of Leukemia
  36. 2,5-Dimethyl-Celecoxib Inhibits Cell Cycle Progression and Induces Apoptosis in Human Leukemia Cells
  37. Signal Transducers and Activators of Transcription (STAT) Regulatory Networks in Marine Organisms: From Physiological Observations towards Marine Drug Discovery
  38. Epipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential
  39. Epipolythiodiketopiperazines from the Marine Derived Fungus Dichotomomyces cejpii with NF-κB Inhibitory Potential
  40. ChemInform Abstract: Oximoaspergillimide, a Fungal Derivative from a Marine Isolate of Aspergillus sp.
  41. Early downregulation of Mcl-1 regulates apoptosis triggered by cardiac glycoside UNBS1450
  42. Bispecific Antibodies: An Innovative Arsenal to Hunt, Grab and Destroy Cancer Cells
  43. A Survey of Marine Natural Compounds and Their Derivatives with Anti-Cancer Activity Reported in 2012
  44. Dual Induction of Mitochondrial Apoptosis and Senescence in Chronic Myelogenous Leukemia by Myrtucommulone A
  45. Cancer-type-specific crosstalk between autophagy, necroptosis and apoptosis as a pharmacological target
  46. Melatonin promotes Bax sequestration to mitochondria reducing cell susceptibility to apoptosis via the lipoxygenase metabolite 5-hydroxyeicosatetraenoic acid
  47. Oximoaspergillimide, a Fungal Derivative from a Marine Isolate ofAspergillussp.
  48. Histone deacetylase 6 in health and disease
  49. Tanzawaic acids isolated from a marine-derived fungus of the genus Penicillium with cytotoxic activities
  50. Curcumin
  51. Nutritional Epigenetic Regulators in the Field of Cancer
  52. Antagonistic role of natural compounds in mTOR-mediated metabolic reprogramming
  53. Hybrid Curcumin Compounds: A New Strategy for Cancer Treatment
  54. Metabolism 2014 – Alterations of metabolic pathways as therapeutic targets
  55. Valproic acid regulates erythro-megakaryocytic differentiation through the modulation of transcription factors and microRNA regulatory micro-networks
  56. Plant-derived epigenetic modulators for cancer treatment and prevention
  57. Energy restriction mimetic agents to target cancer cells: Comparison between 2-deoxyglucose and thiazolidinediones
  58. Modulatory roles of glycolytic enzymes in cell death
  59. From nature to bedside: Pro-survival and cell death mechanisms as therapeutic targets in cancer treatment
  60. P53 and Sirt1: Routes of metabolism and genome stability
  61. Synthesis and bioactivity of novel amino-pyrazolopyridines
  62. Eurycomanone and Eurycomanol from Eurycoma longifolia Jack as Regulators of Signaling Pathways Involved in Proliferation, Cell Death and Inflammation
  63. Epigenetic modulators from “The Big Blue”: A treasure to fight against cancer
  64. Methylenedioxy flavonoids: Assessment of cytotoxic and anti-cancer potential in human leukemia cells
  65. Inhibitory effect of St. John׳s Wort oil macerates on TNFα-induced NF-κB activation and their fatty acid composition
  66. Novel inhibitors of human histone deacetylases: Design, synthesis and bioactivity of 3-alkenoylcoumarines
  67. Regulation of epigenetic traits of the glutathione S-transferase P1 gene: from detoxification toward cancer prevention and diagnosis
  68. Plumbagin Modulates Leukemia Cell Redox Status
  69. Cytotoxic activity and mechanism of action of metabolites from the Goniothalamus genus
  70. 246: Effects of the potential energy restriction mimetic agent delta2-troglitazone in breast cancer cells
  71. Bis(4-hydroxy-2H-chromen-2-one): Synthesis and effects on leukemic cell lines proliferation and NF-κB regulation
  72. 5-aza-2′-deoxycytidine-mediated c-myc Down-regulation Triggers Telomere-dependent Senescence by Regulating Human Telomerase Reverse Transcriptase in Chronic Myeloid Leukemia
  73. Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity
  74. Celecoxib prevents curcumin-induced apoptosis in a hematopoietic cancer cell model
  75. Non-Edible Plants as an Attractive Source of Compounds with Chemopreventive Potential
  76. Antiproliferative and proapoptotic activities of 4-hydroxybenzoic acid-based inhibitors of histone deacetylases
  77. Synthetic polysulfane derivatives induce cell cycle arrest and apoptotic cell death in human hematopoietic cancer cells
  78. Protein Kinase and HDAC Inhibitors from the Endophytic Fungus Epicoccum nigrum
  79. Selective Non-nucleoside Inhibitors of Human DNA Methyltransferases Active in Cancer Including in Cancer Stem Cells
  80. Pro-Apoptotic and Immunostimulatory Tetrahydroxanthone Dimers from the Endophytic Fungus Phomopsis longicolla
  81. PPARγ-inactive Δ2-troglitazone independently triggers ER stress and apoptosis in breast cancer cells
  82. Anticancer bioactivity of compounds from medicinal plants used in European medieval traditions
  83. A novel coumarin-quinone derivative SV37 inhibits CDC25 phosphatases, impairs proliferation, and induces cell death
  84. Anti-Inflammatory and Anticancer Drugs from Nature
  85. Polyphenol tri-vanillic ester 13c inhibits P-JAK2V617F and Bcr–Abl oncokinase expression in correlation with STAT3/STAT5 inactivation and apoptosis induction in human leukemia cells
  86. Anticancer effects of bioactive berry compounds
  87. The DNA hypomethylating agent, 5‐aza‐2′‐deoxycytidine, enhances tumor cell invasion through a transcription‐dependent modulation of MMP‐1 expression in human fibrosarcoma cells
  88. Styryl-lactone goniothalamin inhibits TNF-α-induced NF-κB activation
  89. 1,000 Ways to die: natural compounds modulate non-canonical cell death pathways in cancer cells
  90. Long and Short Non-Coding RNAs as Regulators of Hematopoietic Differentiation
  91. Goniolandrene A and B from Goniothalamus macrophyllus
  92. Anticancer effect of altersolanol A, a metabolite produced by the endophytic fungus Stemphylium globuliferum, mediated by its pro-apoptotic and anti-invasive potential via the inhibition of NF-κB activity
  93. Selective modulation of the glucocorticoid receptor can distinguish between transrepression of NF-κB and AP-1
  94. Curcumin as a regulator of epigenetic events
  95. Cardiac glycosides in cancer therapy: from preclinical investigations towards clinical trials
  96. Assembling the puzzle of anti-cancer mechanisms triggered by cardiac glycosides
  97. Embellicines A and B: Absolute Configuration and NF-κB Transcriptional Inhibitory Activity
  98. In vitro characterisation of the anti-intravasative properties of the marine product heteronemin
  99. A Survey of Marine Natural Compounds and Their Derivatives with Anti-Cancer Activity Reported in 2011
  100. Epigenetically induced changes in nuclear textural patterns and gelatinase expression in human fibrosarcoma cells
  101. A LIM Domain Protein from Tobacco Involved in Actin-Bundling and Histone Gene Transcription
  102. Parkinson’s Disease: A Complex Interplay of Mitochondrial DNA Alterations and Oxidative Stress
  103. Venus Flytrap (Dionaea muscipula Solander ex Ellis) Contains Powerful Compounds that Prevent and Cure Cancer
  104. Metabolism and Cancer: Old and New Players
  105. Natural Compounds as Regulators of the Cancer Cell Metabolism
  106. Live longer, drink (poly)phenols!
  107. Redox regulation – Natural compound as regulators of inflammation signaling
  108. Chromatin-modifying agents in anti-cancer therapy
  109. Traditional West African pharmacopeia, plants and derived compounds for cancer therapy
  110. Development of a matrix-assisted laser desorption/ionization–mass spectrometry screening test to evidence reversible and irreversible inhibitors of CDC25 phosphatases
  111. Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib
  112. ROS-independent JNK activation and multisite phosphorylation of Bcl-2 link diallyl tetrasulfide-induced mitotic arrest to apoptosis
  113. Natural chalcones as dual inhibitors of HDACs and NF-κB
  114. MicroRNAs in cancer management and their modulation by dietary agents
  115. Identification of Differentially Expressed Proteins in Curcumin-Treated Prostate Cancer Cell Lines
  116. ChemInform Abstract: Aurones: Interesting Natural and Synthetic Compounds with Emerging Biological Potential
  117. Power from the Garden: Plant Compounds as Inhibitors of the Hallmarks of Cancer
  118. DNA demethylation increases sensitivity of neuroblastoma cells to chemotherapeutic drugs
  119. Histone deacetylase modulators provided by Mother Nature
  120. New nodulopeptins from Nodularia spumigena KAC 66
  121. Integrated Cellular Pathology—Systems Biology of Human Diseases
  122. OMICS, a multidisciplinary friendship
  123. Dietary compounds as potent inhibitors of the signal transducers and activators of transcription (STAT) 3 regulatory network
  124. Epigenetics Offer New Horizons for Colorectal Cancer Prevention
  125. Targeting the Wingless Signaling Pathway with Natural Compounds as Chemopreventive or Chemotherapeutic Agents
  126. Natural compounds as inducers of cell death
  127. Oxidative Stress, DNA Damage, and c-Abl Signaling: At the Crossroad in Neurodegenerative Diseases?
  128. Naturally Occurring Organic Sulfur Compounds: An Example of a Multitasking Class of Phytochemicals in Anti-Cancer Research
  129. Integrated cellular pathology—Systems biology of human diseases
  130. DNA damage response: The emerging role of c-Abl as a regulatory switch?
  131. COX-2 inhibitors block chemotherapeutic agent-induced apoptosis prior to commitment in hematopoietic cancer cells
  132. Erythropoietin, erythropoiesis and beyond
  133. Epigenomics of leukemia: from mechanisms to therapeutic applications
  134. Conference Scene: Omic technologies in human disease: extending the network of epigenetic control
  135. Cox-2 inhibitors induce early c-Myc downregulation and lead to expression of differentiation markers in leukemia cells
  136. Gold from the sea: Marine compounds as inhibitors of the hallmarks of cancer
  137. The aromatic ketone 4′-hydroxychalcone inhibits TNFα-induced NF-κB activation via proteasome inhibition
  138. Quercetin downregulates Mcl-1 by acting on mRNA stability and protein degradation
  139. Tumor necrosis factor alpha-mediated inhibition of erythropoiesis involves GATA-1/GATA-2 balance impairment and PU.1 over-expression
  140. A Survey of Marine Natural Compounds and Their Derivatives with Anti-Cancer Activity Reported in 2010
  141. Reversible epigenetic fingerprint-mediated glutathione-S-transferase P1 gene silencing in human leukemia cell lines
  142. Selective Antimicrobial Activity Associated with Sulfur Nanoparticles
  143. Antioxidant and anti-proliferative properties of lycopene
  144. Natural compounds as inflammation inhibitors
  145. Abstract LB-277: Dynamic functional analysis of the response of cancer cell lines to the drug UNBS1450
  146. Antiproliferative effect of natural tetrasulfides in human breast cancer cells is mediated through the inhibition of the cell division cycle 25 phosphatases
  147. Chemical Properties and Mechanisms Determining the Anti-Cancer Action of Garlic-Derived Organic Sulfur Compounds
  148. Magnetic fields promote a pro-survival non-capacitative Ca2+ entry via phospholipase C signaling
  149. Anti-proliferative potential of curcumin in androgen-dependent prostate cancer cells occurs through modulation of the Wingless signaling pathway
  150. Dietary chalcones with chemopreventive and chemotherapeutic potential
  151. Valproic acid perturbs hematopoietic homeostasis by inhibition of erythroid differentiation and activation of the myelo-monocytic pathway
  152. Sustained exposure to the DNA demethylating agent, 2′-deoxy-5-azacytidine, leads to apoptotic cell death in chronic myeloid leukemia by promoting differentiation, senescence, and autophagy
  153. Interactions of polysulfanes with components of red blood cells
  154. UNBS1450, a steroid cardiac glycoside inducing apoptotic cell death in human leukemia cells
  155. NF kappa B inhibitors and antitrypanosomal metabolites from endophytic fungus Penicillium sp. isolated from Limonium tubiflorum
  156. Anti-inflammatory, pro-apoptotic, and anti-proliferative effects of a methanolic neem (Azadirachta indica) leaf extract are mediated via modulation of the nuclear factor-κB pathway
  157. Targeting COX-2 expression by natural compounds: A promising alternative strategy to synthetic COX-2 inhibitors for cancer chemoprevention and therapy
  158. Marine natural products targeting phospholipases A2
  159. Melatonin: A pleiotropic molecule regulating inflammation
  160. Inflammation: Novel arrows for an ancient target
  161. Multistep and multitask Bax activation
  162. Photosynthetic marine organisms as a source of anticancer compounds
  163. Synthesis and Selective Anticancer Activity of Organochalcogen Based Redox Catalysts
  164. Potential of the Dietary Antioxidants Resveratrol and Curcumin in Prevention and Treatment of Hematologic Malignancies
  165. Anemia in cancer
  166. Synthesis and cytotoxic potential of heterocyclic cyclohexanone analogues of curcumin
  167. Decrypting the labyrinth of inflammatory cell signaling pathways
  168. Corrigendum to “Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death” [Biochem. Pharmacol. 79 (2010) 610–622]
  169. Sp proteins play a critical role in histone deacetylase inhibitor-mediated derepression ofCYP46A1gene transcription
  170. Naturally Occurring Regulators of Histone Acetylation/Deacetylation
  171. Heteronemin, a spongean sesterterpene, inhibits TNFα-induced NF-κB activation through proteasome inhibition and induces apoptotic cell death
  172. Diallylpolysulfides induce growth arrest and apoptosis
  173. Curcumin―The Paradigm of a Multi-Target Natural Compound with Applications in Cancer Prevention and Treatment
  174. Dermacozines, a new phenazine family from deep-sea dermacocci isolated from a Mariana Trench sediment
  175. The Dual Role of Calcium as Messenger and Stressor in Cell Damage, Death, and Survival
  176. Molecular and Therapeutic Potential and Toxicity of Valproic Acid
  177. The Role of Cyclooxygenase-2 in Cell Proliferation and Cell Death in Human Malignancies
  178. Chemopreventive potential of curcumin in prostate cancer
  179. The inhibition of TNF-α-induced NF-κB activation by marine natural products
  180. Bioactive Diterpene Derivatives from the Marine Sponge Spongionella sp.
  181. Intracellular Prooxidant Activity of Melatonin Induces a Survival Pathway Involving NF-κB Activation
  182. Preface
  183. Effect of Curcumin on Nuclear Factor κB Signaling Pathways in Human Chronic Myelogenous K562 Leukemia Cells
  184. Subapoptogenic Oxidative Stress Strongly Increases the Activity of the Glycolytic Key Enzyme Glyceraldehyde 3-Phosphate Dehydrogenase
  185. Gene Expression Profiling Related to Anti-inflammatory Properties of Curcumin in K562 Leukemia Cells
  186. Preface
  187. UNBS1450 from Calotropis procera as a regulator of signaling pathways involved in proliferation and cell death
  188. Induction of heat shock response by curcumin in human leukemia cells
  189. Linking anemia to inflammation and cancer: The crucial role of TNFα
  190. Cell cycle arrest in early mitosis and induction of caspase-dependent apoptosis in U937 cells by diallyltetrasulfide (Al2S4)
  191. Potential role of organic sulfur compounds from Allium species in cancer prevention and therapy
  192. The inhibitory effect of the proinflammatory cytokine TNFα on erythroid differentiation involves erythroid transcription factor modulation
  193. Tumor necrosis factor α induces γ-glutamyltransferase expression via nuclear factor-κB in cooperation with Sp1
  194. Pro-Inflammatory Cytokine-Mediated Anemia: Regarding Molecular Mechanisms of Erythropoiesis
  195. Modulation of anti-apoptotic and survival pathways by curcumin as a strategy to induce apoptosis in cancer cells
  196. Novel job opportunities in cell death!
  197. Oxidation-dependent maturation and survival of explanted blood monocytes via Bcl-2 up-regulation
  198. Tumor necrosis factor α inhibits erythroid differentiation in human erythropoietin-dependent cells involving p38 MAPK pathway, GATA-1 and FOG-1 downregulation and GATA-2 upregulation
  199. Corrigendum
  200. Oxidative, multistep activation of the noncanonical NF- B pathway via disulfide Bcl-3/p50 complex
  201. Naturally occurring reactive sulfur species, their activity against Caco-2 cells, and possible modes of biochemical action
  202. Marine metabolites as pharmacophores and biomedical research tools
  203. Erratum for Ann. N.Y. Acad. Sci. 1010: 441-445. Apoptosis: From Signaling Pathways to Therapeutic Tools Marc Diederich, Ed.
  204. NF-κB Inhibiting Naphthopyrones from the Fijian Echinoderm Comanthus parvicirrus
  205. Long live the cell death!
  206. Melatonin antagonizes the intrinsic pathway of apoptosis via mitochondrial targeting of Bcl-2
  207. Marine natural products as targeted modulators of the transcription factor NF-κB
  208. Radicicol-mediated inhibition of Bcr-Ab1 in K562 cells induced p38-MAPK dependent erythroid differentiation and PU.1 down-regulation
  209. NF-κB-Inhibiting Naphthopyrones from the Fijian Echinoderm Comanthus parvicirrus
  210. Sequential phases of Ca2+ alterations in pre-apoptotic cells
  211. Preface
  212. Effect of Curcumin Treatment on Protein Phosphorylation in K562 Cells
  213. Oxidative Upregulation of Bcl-2 in Healthy Lymphocytes
  214. Preface
  215. Curcumin regulates signal transducer and activator of transcription (STAT) expression in K562 cells
  216. Tumor necrosis factor alpha inhibits aclacinomycin A-induced erythroid differentiation of K562 cells via GATA-1
  217. Transcriptional and post-transcriptional regulation of glutathione S-transferase P1 expression during butyric acid-induced differentiation of K562 cells
  218. Inhibition of TNFα-induced activation of nuclear factor κB by kava (Piper methysticum) derivatives
  219. Chemopreventive and therapeutic effects of curcumin
  220. Preface
  221. GATA-1: Friends, Brothers, and Coworkers
  222. Curcumin Stability and Its Effect on GlutathioneS-Transferase P1-1 mRNA Expression in K562 Cells
  223. Expression of glutathione S-transferase P1-1 in leukemic cells is regulated by inducible AP-1 binding
  224. A Beginner's Guide to NF-κB Signaling Pathways
  225. Signal Transduction and Chromatin, 2004
  226. Modulation of poly(ADP-ribosylation) in apoptotic cells
  227. Effect of chemopreventive agents on glutathione S-transferase P1-1 gene expression mechanisms via activating protein 1 and nuclear factor kappaB inhibition
  228. Increased glutathione S-transferase P1-1 expression by mRNA stabilization in hemin-induced differentiation of K562 cells
  229. Regulation of glutathione S-transferase P1-1 gene expression by NF-kappaB in tumor necrosis factor alpha-treated K562 leukemia cells
  230. Phorbol ester regulation of the human γ-glutamyltransferase gene promoter
  231. Preface
  232. An Introduction to the Molecular Mechanisms of Apoptosis
  233. Curcumin-Induced Cell Death in Two Leukemia Cell Lines: K562 and Jurkat
  234. Expression of glutathione S-transferase P1-1 in differentiating K562: role of GATA-1
  235. Apoptosis 2003—from signalling pathways to therapeutic tools
  236. Induction of apoptosis by curcumin: mediation by glutathione S-transferase P1-1 inhibition
  237. Preface
  238. Cell signaling, transcription and translation as therapeutic targets
  239. Phorbol ester responsiveness of the glutathione S-transferase P1 gene promoter involves an inducible c-jun binding in human K562 leukemia cells
  240. Regulation of transcription of the glutathione S-transferase P1 gene by methylation of the minimal promoter in human leukemia cells
  241. GTP-mediated differentiation of the human K562 cell line: transient overexpression of GATA-1 and stabilization of the γ-globin mRNA
  242. Localization of a regulatory region on the 5′-untranslated region of human hepatoma HepG2 γ-glutamyltransferase mRNA and response to dexamethasone and antisense oligonucleotide treatment
  243. The 5' untranslated region of the human γ-glutamyl transferase mRNA contains a tissue-specific active translational enhancer
  244. γ-Glutamyltransferase: Nucleotide sequence of the human pancreatic cDNA
  245. Curcumin
  246. Oxidative Stress and Apoptosis